Bristol-Myers Squibb (BMY) stock forecast for 2024. Forecast tables and graphs.

Bristol-Myers Squibb (BMY) stock forecast for 2024

The forecast has been updated: July 28, 2021 5:51


Bristol-Myers stock price online today

Analyst Target Price

75.37

Dividend Date

02.08.2021

Ex Dividend Date

01.07.2021

Last Split Factor

1000000:95

Last Split Date

07.08.2001

Should you buy or sell Bristol-Myers stock stock today? What is the projected target price level for 2024? How much will it cost in 2024? Bristol-Myers stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2024.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $75.37 target price for Bristol-Myers stock stock.

Today 200 Day Moving Average is the support level (64.23 $).

50 Day Moving Average is the resistance level (66.76 $).




BMY Forecast for 2024

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 80.79 77.50 83.41 7.09 %
Feb 81.19 77.98 82.08 5.01 %
Mar 83.74 80.97 86.45 6.34 %
Apr 82.22 79.82 84.34 5.36 %
May 85.38 82.19 86.93 5.46 %
Jun 89.14 88.16 92.72 4.92 %
Jul 88.70 87.43 90.21 3.08 %
Aug 92.36 88.65 94.44 6.13 %
Sep 95.91 94.28 99.39 5.15 %
Oct 95.70 92.81 97.86 5.16 %
Nov 94.54 92.83 98.70 5.95 %
Dec 93.87 92.83 96.91 4.21 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Bristol-Myers stock.


Bristol-Myers overview

Bristol-Myers Address

430 E. 29TH STREET, 14 FLOOR, NEW YORK, NY, US

Market Capitalization

150 694 363 000 $

EBITDA

18 342 001 000

PE Ratio

None

PEG Ratio

32.33

Dividend Per Share

1.88

Dividend Yield

0.0278

EPS

-2.78

Quarterly Earnings Growth YOY

-0.011

Quarterly Revenue Growth YOY

0.027

Trailing PE

0

Forward PE

9.05

EV To Revenue

4.362

EV To EBITDA

23.5

52 Week High

68.53

52 Week Low

55.19

50 Day Moving Average

66.76

200 Day Moving Average

64.23

Shares Outstanding

2232840000

Shares Float

2198592000

Shares Short Prior Month

20791300

Short Ratio

2.1

Percent Insiders

0.068

Percent Institutions

74.87

Bristol-Myers stock forecast for this year


Bristol-Myers stock forecast for Jan 2024.
Estimated Average Forecasted Bristol-Myers Price: 80.79. Negative monthly dynamics of the instrument is expected with 7.085% volatility is expected.

Pessimistic forecast: 77.50

Optimistic: 83.41


Bristol-Myers stock forecast for Feb 2024.
Estimated Average Forecasted Bristol-Myers Price: 81.19. Positive monthly dynamics of the instrument is expected with 5.005% volatility is expected.

Pessimistic forecast: 77.98

Optimistic: 82.08


Bristol-Myers stock forecast for Mar 2024.
Estimated Average Forecasted Bristol-Myers Price: 83.74. Positive monthly dynamics of the instrument is expected with 6.339% volatility is expected.

Pessimistic forecast: 80.97

Optimistic: 86.45


Bristol-Myers stock forecast for Apr 2024.
Estimated Average Forecasted Bristol-Myers Price: 82.22. Negative monthly dynamics of the instrument is expected with 5.361% volatility is expected.

Pessimistic forecast: 79.82

Optimistic: 84.34


Bristol-Myers stock forecast for May 2024.
Estimated Average Forecasted Bristol-Myers Price: 85.38. Positive monthly dynamics of the instrument is expected with 5.456% volatility is expected.

Pessimistic forecast: 82.19

Optimistic: 86.93


Bristol-Myers stock forecast for Jun 2024.
Estimated Average Forecasted Bristol-Myers Price: 89.14. Positive monthly dynamics of the instrument is expected with 4.918% volatility is expected.

Pessimistic forecast: 88.16

Optimistic: 92.72


Bristol-Myers stock forecast for Jul 2024.
Estimated Average Forecasted Bristol-Myers Price: 88.70. Negative monthly dynamics of the instrument is expected with 3.082% volatility is expected.

Pessimistic forecast: 87.43

Optimistic: 90.21


Bristol-Myers stock forecast for Aug 2024.
Estimated Average Forecasted Bristol-Myers Price: 92.36. Positive monthly dynamics of the instrument is expected with 6.132% volatility is expected.

Pessimistic forecast: 88.65

Optimistic: 94.44


Bristol-Myers stock forecast for Sep 2024.
Estimated Average Forecasted Bristol-Myers Price: 95.91. Positive monthly dynamics of the instrument is expected with 5.148% volatility is expected.

Pessimistic forecast: 94.28

Optimistic: 99.39


Bristol-Myers stock forecast for Oct 2024.
Estimated Average Forecasted Bristol-Myers Price: 95.70. Negative monthly dynamics of the instrument is expected with 5.164% volatility is expected.

Pessimistic forecast: 92.81

Optimistic: 97.86


Bristol-Myers stock forecast for Nov 2024.
Estimated Average Forecasted Bristol-Myers Price: 94.54. Negative monthly dynamics of the instrument is expected with 5.953% volatility is expected.

Pessimistic forecast: 92.83

Optimistic: 98.70


Bristol-Myers stock forecast for Dec 2024.
Estimated Average Forecasted Bristol-Myers Price: 93.87. Negative monthly dynamics of the instrument is expected with 4.209% volatility is expected.

Pessimistic forecast: 92.83

Optimistic: 96.91



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 121.09 (29.07.2021) 0.47 %
AbbVie Inc.
ABBV 118.87 (29.07.2021) 0.27 %
Aeterna Zentaris Inc.
AEZS 0.7254 (29.07.2021) -6.38 %
Allakos Inc.
ALLK 81.5 (29.07.2021) -0.40 %
Allogene Therapeutics, Inc.
ALLO 22.37 (29.07.2021) -0.89 %
Amgen Inc.
AMGN 242.46 (29.07.2021) -0.73 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 13.05 (29.07.2021) -1.06 %
Aurora Cannabis Inc.
ACB 7.11 (29.07.2021) -2.47 %
Becton Dickinson and Company
BDX 255.31 (29.07.2021) 0.72 %
Biogen Inc.
BIIB 329.17 (29.07.2021) -1.50 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 126.14 (29.07.2021) -0.96 %
BioNTech SE
BNTX 312.59 (29.07.2021) -0.27 %
bluebird bio, Inc.
BLUE 25.66 (29.07.2021) -1.31 %
Boston Scientific Corp.
BSX 45.32 (29.07.2021) -0.24 %
Bristol-Myers Squibb Company
BMY 68.15 (29.07.2021) -0.84 %
Canopy Growth Corp.
CGC 19.54 (29.07.2021) -0.31 %
Castle Biosciences, Inc.
CSTL 68.51 (29.07.2021) -0.20 %
Eli Lilly and Company
LLY 245.33 (29.07.2021) -0.48 %
Emergent BioSolutions Inc.
EBS 65.22 (29.07.2021) 0.09 %
Exelixis, Inc.
EXEL 16.86 (29.07.2021) -1.63 %
G1 Therapeutics, Inc.
GTHX 17.38 (29.07.2021) -3.82 %
Gilead Sciences, Inc.
GILD 69.83 (29.07.2021) -0.33 %
GlaxoSmithKline plc
GSK 40.1 (29.07.2021) 1.52 %
GoodRx Holdings, Inc.
GDRX 32.52 (29.07.2021) -0.91 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 77.4 (29.07.2021) -0.78 %
Inovio Pharmaceuticals, Inc.
INO 8.5 (29.07.2021) -1.96 %
Johnson & Johnson
JNJ 172.18 (29.07.2021) 0.00 %
Medtronic plc.
MDT 130.68 (29.07.2021) 0.12 %
Merck & Co., Inc.
MRK 76.93 (29.07.2021) -1.79 %
Moderna, Inc.
MRNA 345.64 (29.07.2021) -1.05 %
Novartis AG
NVS 92.19 (29.07.2021) 0.33 %
Novavax, Inc.
NVAX 184 (29.07.2021) -2.65 %
ObsEva SA
OBSV 2.59 (29.07.2021) -1.52 %
OrganiGram Holdings Inc.
OGI 2.65 (29.07.2021) -2.93 %
Pfizer Inc.
PFE 42.79 (29.07.2021) -1.52 %
Regeneron Pharmaceuticals, Inc.
REGN 583.13 (29.07.2021) -0.56 %
Sanofi
SNY 51.53 (29.07.2021) -1.02 %
Schrodinger, Inc.
SDGR 68.33 (29.07.2021) -2.55 %
Senseonics Holdings, Inc.
SENS 3.05 (29.07.2021) -0.97 %
Sorrento Therapeutics, Inc.
SRNE 8.39 (29.07.2021) -2.21 %
Stryker Corp.
SYK 269.18 (29.07.2021) 0.19 %
Sundial Growers Inc.
SNDL 0.823 (29.07.2021) -3.18 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 9.69 (29.07.2021) -3.00 %
Thermo Fisher Scientific Inc.
TMO 533.77 (29.07.2021) 1.04 %
Tilray, Inc.
TLRY 15.42 (29.07.2021) -3.69 %
UnitedHealth Group, Inc.
UNH 412.08 (29.07.2021) 0.71 %
Veeva Systems Inc.
VEEV 332.61 (29.07.2021) 0.15 %
Zomedica Corp.
ZOM 0.61 (29.07.2021) -4.42 %
Zynerba Pharmaceuticals, Inc.
ZYNE 4.53 (29.07.2021) -3.62 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.